ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Forecast, Price Target & Analyst Ratings

EPA:ALOPM • FR001400CM63

Current stock price

0.475 EUR
-0.01 (-1.45%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ONCODESIGN PRECISION MEDICIN (ALOPM.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€2.04
+ 329.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 3, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€2.04
Upside
+ 329.47%
From current price of €0.48 to mean target of €2.04, Based on 9 analyst forecasts
Low
€2.02
Median
€2.04
High
€2.10

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for ALOPM.PA. The average price target is 2.04 EUR. This implies a price increase of 329.47% is expected in the next year compared to the current price of 0.475.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALOPM Current Analyst RatingALOPM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ALOPM Historical Analyst RatingsALOPM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
ALOPM.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALOPM.PA.
In the previous month the buy percentage consensus was at a similar level.
ALOPM.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 3, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ALOPM.PA revenue by date.ALOPM.PA revenue by date.
7.98M
108.36%		1.07M
-86.59%		210K
-80.37%		12.154M
5,687.62%		104.85M
762.68%		27.604M
-73.67%
EBITDA
YoY % growth
ALOPM.PA ebitda by date.ALOPM.PA ebitda by date.
N/AN/AN/A
12.63%		515K
106.39%		91.773M
17,720.00%		13.081M
-85.75%
EBIT
YoY % growth
ALOPM.PA ebit by date.ALOPM.PA ebit by date.
-1.61M
56.84%		-9.94M
-517.39%		-7.81M
21.43%		103K
101.32%		91.258M
88,500.00%		12.36M
-86.46%
Operating Margin
ALOPM.PA operating margin by date.ALOPM.PA operating margin by date.
-20.18%-928.97%-3,719.05%0.85%87.04%44.78%
EPS
YoY % growth
ALOPM.PA eps by date.ALOPM.PA eps by date.
N/AN/AN/A
18.37%		-0.02
95.00%		4.15
20,250.00%		0.55
-86.85%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALOPM.PA Yearly Revenue VS EstimatesALOPM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ALOPM.PA Yearly EPS VS EstimatesALOPM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
49.26%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
78.65%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
52.59%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ONCODESIGN PRECISION MEDICIN / ALOPM.PA Forecast FAQ

What is the average price target for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?

9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 329.47% is expected in the next year compared to the current price of 0.475.

When does ONCODESIGN PRECISION MEDICIN (ALOPM.PA) report earnings?

ONCODESIGN PRECISION MEDICIN (ALOPM.PA) will report earnings on 2026-04-03.

How many analysts have analysed ONCODESIGN PRECISION MEDICIN (ALOPM.PA)?

The number of analysts covering ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is 9.